Zhu Y - Search Results

1

Tumor necrosis factor-α-inducible protein 8-like protein 3 (TIPE3): a novel prognostic factor in colorectal cancer.

Xu Y, Zhu Y, Xia H, Wang Y, Li L, Wan H, Zhang S, Xu A, Wang L, Gong J, Zhang P. Xu Y, et al. Among authors: zhu y. BMC Cancer. 2023 Feb 8;23(1):131. doi: 10.1186/s12885-023-10590-2. BMC Cancer. 2023. PMID: 36755222 Free PMC article.

2

A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo.

Yan Y, Cheng X, Li L, Zhang R, Zhu Y, Wu Z, Ding K. Yan Y, et al. Among authors: zhu y. Front Oncol. 2021 May 12;11:669393. doi: 10.3389/fonc.2021.669393. eCollection 2021. Front Oncol. 2021. PMID: 34055637 Free PMC article.

3

NUDT21 Promotes Tumor Growth and Metastasis Through Modulating SGPP2 in Human Gastric Cancer.

Zhu Y, Zhang R, Zhang Y, Cheng X, Li L, Wu Z, Ding K. Zhu Y, et al. Front Oncol. 2021 Sep 30;11:670353. doi: 10.3389/fonc.2021.670353. eCollection 2021. Front Oncol. 2021. PMID: 34660260 Free PMC article.

4

MLF2 Negatively Regulates P53 and Promotes Colorectal Carcinogenesis.

Fang D, Hu H, Zhao K, Xu A, Yu C, Zhu Y, Yu N, Yao B, Tang S, Wu X, Mei Y. Fang D, et al. Among authors: zhu y. Adv Sci (Weinh). 2023 Sep;10(26):e2303336. doi: 10.1002/advs.202303336. Epub 2023 Jul 12. Adv Sci (Weinh). 2023. PMID: 37438558 Free PMC article.

5

Corrigendum: NUDT21 promotes tumor growth and metastasis through modulating SGPP2 in human gastric cancer.

Zhu Y, Zhang R, Zhang Y, Cheng X, Li L, Wu Z, Ding K. Zhu Y, et al. Front Oncol. 2023 Aug 28;13:1240063. doi: 10.3389/fonc.2023.1240063. eCollection 2023. Front Oncol. 2023. PMID: 37700841 Free PMC article.

6

Comprehensive analysis of the prognostic and immunological roles of TIPE3 in Colon Cancer.

Xia HB, Zhu XD, Zhu Y, Xu AM. Xia HB, et al. Among authors: zhu y, zhu xd. Asian J Surg. 2024 Mar;47(3):1530-1532. doi: 10.1016/j.asjsur.2023.11.162. Epub 2023 Dec 8. Asian J Surg. 2024. PMID: 38071098 Free article. No abstract available.

7

CTHRC1 is associated with BRAF(V600E) mutation and correlates with prognosis, immune cell infiltration, and drug resistance in colon cancer, thyroid cancer, and melanoma.

Zhang R, Wang Z, Wang H, Li L, Dong L, Ding L, Li Q, Zhu L, Zhang T, Zhu Y, Ding K. Zhang R, et al. Among authors: zhu y, zhu l. Biomol Biomed. 2024 Dec 11;25(1):42-61. doi: 10.17305/bb.2024.10397. Biomol Biomed. 2024. PMID: 39052013 Free article.

8

Multiomics analysis of homologous recombination deficiency across cancer types.

Dong L, Li L, Zhu L, Xu F, Zhang R, Li Q, Zhu Y, Zeng Z, Ding K. Dong L, et al. Among authors: zhu y, zhu l. Biomol Biomed. 2024 Dec 11;25(1):71-81. doi: 10.17305/bb.2024.10448. Biomol Biomed. 2024. PMID: 39073402 Free article.

9

The β-catenin-LINC00183-miR-371b-5p-Smad2/LEF1 axis promotes adult T-cell lymphoblastic lymphoma progression and chemoresistance.

Huang WJ, Guo SB, Shi H, Li XL, Zhu Y, Li M, Song LY, Yu RM, Cai QQ, Tian XP. Huang WJ, et al. Among authors: zhu y. J Exp Clin Cancer Res. 2023 Apr 28;42(1):105. doi: 10.1186/s13046-023-02670-9. J Exp Clin Cancer Res. 2023. PMID: 37106379 Free PMC article.

10

Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer.

Ding L, Jiang H, Li Q, Li Q, Zhang TT, Shang L, Xie B, Zhu Y, Ding K, Shi X, Zhu T, Zhu Y. Ding L, et al. Among authors: zhu t, zhu y. J Exp Clin Cancer Res. 2024 Mar 25;43(1):90. doi: 10.1186/s13046-024-03016-9. J Exp Clin Cancer Res. 2024. PMID: 38523299 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54,721 results

Search Page

Filters